Cellular senescence in the aging and diseased kidney

Journal of Cell Communication and Signaling

Volumn 12, Issue 1, 2018, Pages 69-82

  Valentijn, F A ^a   Falke, L L ^a,b   Nguyen, T Q ^a   Goldschmeding, Roel ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b DEPARTMENT OF SURGERY   (Netherlands)

Author keywords

Apoptotic balance; Cellular senescence; DNA damage response; Renal aging; Renal disease; Senotherapy

Indexed keywords

APOPTOSIS; CAUSALITY; CELL AGING; CELL CYCLE ARREST; CELLULAR DISTRIBUTION; CHRONIC KIDNEY FAILURE; HUMAN; KIDNEY CELL; KIDNEY DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SENESCENCE; SENESCENCE ASSOCIATED SECRETORY PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 85038365276     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-017-0434-2     Document Type: Review

References (119)

1. Aan GJ, Hairi HA, Makpol S et al (2013) Differences in protein changes between stress-induced premature senescence and replicative senescence states. Electrophoresis 34:2209–2217. https://doi.org/10.1002/elps.201300086
2. d'Adda di Fagagna F (2008) Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer 8:512–522. https://doi.org/10.1038/nrc2440
3. Algire C, Moiseeva O, Deschênes-Simard X et al (2012) Metformin reduces endogenous reactive oxygen species and associated DNA damage. Cancer Prev Res (Phila) 5:536–543. https://doi.org/10.1158/1940-6207.CAPR-11-0536
4. Baar MP, Brandt RMC, Putavet DA et al (2017) Targeted apoptosis of senescent cells restores tissue homeostasis in response to Chemotoxicity and aging. Cell 169:132–147.e16. https://doi.org/10.1016/j.cell.2017.02.031
5. Baisantry A, Bhayana S, Rong S et al (2016) Autophagy induces Prosenescent changes in proximal tubular S3 segments. J Am Soc Nephrol 27:1609–1616. https://doi.org/10.1681/ASN.2014111059
6. Baker DJ, Childs BG, Durik M et al (2016) Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530:184–189. https://doi.org/10.1038/nature16932
7. Bennett BL, Sasaki DT, Murray BW et al (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 98:13681–13686. https://doi.org/10.1073/pnas.251194298
8. Blagosklonny MV (2011) Cell cycle arrest is not senescence. Aging (Albany NY) 3:94–101. 10.18632/aging.100281
9. Bonventre JV (2014a) Maladaptive proximal tubule repair: cell cycle arrest. Nephron Clin Pract 127:61–64. https://doi.org/10.1159/000363673
10. Bonventre JV (2014b) Primary proximal tubule injury leads to epithelial cell cycle arrest, fibrosis, vascular rarefaction, and glomerulosclerosis. Kidney Int Suppl 4(2011):39–44. https://doi.org/10.1038/kisup.2014.8
11. Braun H, Schmidt BMW, Raiss M et al (2012) Cellular senescence limits regenerative capacity and allograft survival. J Am Soc Nephrol 23:1467–1473. https://doi.org/10.1681/ASN.2011100967
12. Burd CE, Sorrentino JA, Clark KS et al (2013) Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model. Cell 152:340–351. https://doi.org/10.1016/j.cell.2012.12.010
13. Campisi J (1997) The biology of rep licative senescence. Eur J Cancer 33:703–709. https://doi.org/10.1016/S0959-8049(96)00058-5
14. Campisi J, d'Adda di Fagagna F (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8:729–740. https://doi.org/10.1038/nrm2233
15. Cesare AJ, Hayashi MT, Crabbe L, Karlseder J (2013) The telomere deprotection response is functionally distinct from the genomic DNA damage response. Mol Cell 51:141–155. https://doi.org/10.1016/j.molcel.2013.06.006
16. Chang J, Wang Y, Shao L et al (2016) Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat Med 22:78–83. https://doi.org/10.1038/nm.4010
17. Chen X, Ko LJ, Jayaraman L, Prives C (1996) p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 10:2438–2451
18. Chen L, Willis SN, Wei A et al (2005) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17:393–403. https://doi.org/10.1016/j.molcel.2004.12.030
19. Childs BG, Durik M, Baker DJ, van Deursen JM (2015) Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med 21:1424–1435. https://doi.org/10.1038/nm.4000
20. Chkhotua AB, Gabusi E, Altimari A et al (2003) Increased expression of p16(INK4a) and p27(Kip1) cyclin-dependent kinase inhibitor genes in aging human kidney and chronic allograft nephropathy. Am J Kidney Dis 41:1303–1313
21. Choi CHJ, Zuckerman JE, Webster P, Davis ME (2011) Targeting kidney mesangium by nanoparticles of defined size. Proc Natl Acad Sci U S A 108:6656–6661. https://doi.org/10.1073/pnas.1103573108
22. Christensen EI, Birn H, Storm T et al (2012) Endocytic receptors in the renal proximal tubule. Physiology (Bethesda) 27:223–236. https://doi.org/10.1152/physiol.00022.2012
23. Clements ME, Chaber CJ, Ledbetter SR, Zuk A (2013) Increased cellular senescence and vascular rarefaction exacerbate the progression of kidney fibrosis in aged mice following transient ischemic injury. PLoS One 8:e70464. https://doi.org/10.1371/journal.pone.0070464
24. Coppé J-P, Patil CK, Rodier F et al (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6:2853–2868. https://doi.org/10.1371/journal.pbio.0060301
25. Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038–2047. https://doi.org/10.1001/jama.298.17.2038
26. Crosio C, Fimia GM, Loury R et al (2002) Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian aurora kinases. Mol Cell Biol 22:874–885. https://doi.org/10.1128/MCB.22.3.874-885.2002
27. Datto MB, Li Y, Panus JF et al (1995) Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci U S A 92:5545–5549
28. el-Deiry WS, Tokino T, Velculescu VE et al (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75:817–825
29. Demaria M, Ohtani N, Youssef SA et al (2014) An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev Cell 31:722–733. https://doi.org/10.1016/j.devcel.2014.11.012
30. Dimri GP, Lee X, Basile G et al (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92:9363–9367
31. Ding G, Franki N, Kapasi AA et al (2001) Tubular cell senescence and expression of TGF-beta1 and p21(WAF1/CIP1) in tubulointerstitial fibrosis of aging rats. Exp Mol Pathol 70:43–53. https://doi.org/10.1006/exmp.2000.2346
32. Dörr JR, Yu Y, Milanovic M et al (2013) Synthetic lethal metabolic targeting of cellular senescence in cancer therapy. Nature 501:421–425. https://doi.org/10.1038/nature12437
33. Falke LL, Gholizadeh S, Goldschmeding R et al (2015) Diverse origins of the myofibroblast—implications for kidney fibrosis. Nat Rev Nephrol 11:233–244. https://doi.org/10.1038/nrneph.2014.246
34. Franssen EJ, Moolenaar F, de Zeeuw D, Meijer DK (1993) Low-molecular-weight proteins as carriers for renal drug targeting. Contrib Nephrol 101:99–103
35. Ghosal G, Chen J (2013) DNA damage tolerance: a double-edged sword guarding the genome. Transl Cancer Res 2:107–129. https://doi.org/10.3978/j.issn.2218-676X.2013.04.01
36. Gil J, Peters G (2006) Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 7:667–677. https://doi.org/10.1038/nrm1987
37. Gire V, Dulic V (2015) Senescence from G2 arrest, revisited. Cell Cycle 14:297–304. https://doi.org/10.1080/15384101.2014.1000134
38. Harper JW, Adami GR, Wei N et al (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805–816
39. Heydari AR, Unnikrishnan A, Lucente LV, Richardson A (2007) Caloric restriction and genomic stability. Nucleic Acids Res 35:7485–7496. https://doi.org/10.1093/nar/gkm860
40. Hill NR, Fatoba ST, Oke JL et al (2016) Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One 11:e0158765. https://doi.org/10.1371/journal.pone.0158765
41. Hochegger K, Koppelstaetter C, Tagwerker A et al (2007) p21 and mTERT are novel markers for determining different ischemic time periods in renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 292:F762–F768. https://doi.org/10.1152/ajprenal.00084.2006
42. Holmström KM, Finkel T (2014) Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol 15:411–421. https://doi.org/10.1038/nrm3801
43. Iglesias-Bartolome R, Patel V, Cotrim A et al (2012) mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis. Cell Stem Cell 11:401–414. https://doi.org/10.1016/j.stem.2012.06.007
44. Inoki K, Kim J, Guan K-L (2012) AMPK and mTOR in cellular energy homeostasis and drug targets. Annu Rev Pharmacol Toxicol 52:381–400. https://doi.org/10.1146/annurev-pharmtox-010611-134537
45. Jackson SP, Bartek J (2009) The DNA-damage response in human biology and disease. Nature 461:1071–1078. https://doi.org/10.1038/nature08467
46. Johmura Y, Shimada M, Misaki T et al (2014) Necessary and sufficient role for a mitosis skip in senescence induction. Mol Cell 55:73–84. https://doi.org/10.1016/j.molcel.2014.05.003
47. Jullien L, Mestre M, Roux P, Gire V (2013) Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response. Nucleic Acids Res 41:900–911. https://doi.org/10.1093/nar/gks1121
48. Jun J-I, Lau LF (2010) The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol 12:676–685. https://doi.org/10.1038/ncb2070
49. Kamada H, Tsutsumi Y, Sato-Kamada K et al (2003) Synthesis of a poly(vinylpyrrolidone-co-dimethyl maleic anhydride) co-polymer and its application for renal drug targeting. Nat Biotechnol 21:399–404. https://doi.org/10.1038/nbt798
50. Kamaly N, He JC, Ausiello DA, Farokhzad OC (2016) Nanomedicines for renal disease: current status and future applications. Nat Rev Nephrol 12:738–753. https://doi.org/10.1038/nrneph.2016.156
51. Kang T-W, Yevsa T, Woller N et al (2011) Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479:547–551. https://doi.org/10.1038/nature10599
52. Khanna AK, Pieper GM (2007) NADPH oxidase subunits (NOX-1, p22phox, Rac-1) and tacrolimus-induced nephrotoxicity in a rat renal transplant model. Nephrol Dial Transplant 22:376–385. https://doi.org/10.1093/ndt/gfl608
53. Khoo KH, Hoe KK, Verma CS, Lane DP (2014) Drugging the p53 pathway: understanding the route to clinical efficacy. Nat Rev Drug Discov 13:217–236. https://doi.org/10.1038/nrd4236
54. Kim K-H, Chen C-C, Monzon RI, Lau LF (2013) Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts. Mol Cell Biol 33:2078–2090. https://doi.org/10.1128/MCB.00049-13
55. Kitada K, Nakano D, Ohsaki H et al (2014) Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent pathway in proximal tubules in the early stage of diabetic nephropathy. J Diabetes Complicat 28:604–611. https://doi.org/10.1016/j.jdiacomp.2014.05.010
56. Kloner RA, Shi J, Dai W (2015) New therapies for reducing post-myocardial left ventricular remodeling. Ann Transl Med 3:20. https://doi.org/10.3978/j.issn.2305-5839.2015.01.13
57. Kracikova M, Akiri G, George A et al (2013) A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis. Cell Death Differ 20:576–588. https://doi.org/10.1038/cdd.2012.155
58. Krishnamurthy J, Torrice C, Ramsey MR et al (2004) Ink4a/Arf expression is a biomarker of aging. J Clin Invest 114:1299–1307. https://doi.org/10.1172/JCI22475
59. Krizhanovsky V, Yon M, Dickins RA et al (2008) Senescence of activated stellate cells limits liver fibrosis. Cell 134:657–667. https://doi.org/10.1016/j.cell.2008.06.049
60. Krtolica A, Parrinello S, Lockett S et al (2001) Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A 98:12072–12077. https://doi.org/10.1073/pnas.211053698
61. Le Clef N, Verhulst A, D'Haese PC, Vervaet BA (2016) Unilateral renal ischemia-reperfusion as a robust model for acute to chronic kidney injury in mice. PLoS One 11:e0152153. https://doi.org/10.1371/journal.pone.0152153
62. Lee DH, Wolstein JM, Pudasaini B, Plotkin M (2012) INK4a deletion results in improved kidney regeneration and decreased capillary rarefaction after ischemia-reperfusion injury. Am J Physiol Renal Physiol 302:F183–F191. https://doi.org/10.1152/ajprenal.00407.2011
63. Lin Y, Li Y, Wang X et al (2013) Targeted drug delivery to renal proximal tubule epithelial cells mediated by 2-glucosamine. J Control Release 167:148–156. https://doi.org/10.1016/j.jconrel.2013.02.001
64. Littlewood TD, Bennett MR (2007) Foxing smooth muscle cells: FOXO3a-CYR61 connection. Circ Res 100:302–304. https://doi.org/10.1161/01.RES.0000259101.39931.d3
65. Liu J, Yang J-R, He Y-N et al (2012a) Accelerated senescence of renal tubular epithelial cells is associated with disease progression of patients with immunoglobulin a (IgA) nephropathy. Transl Res 159:454–463. https://doi.org/10.1016/j.trsl.2011.11.008
66. Liu J, Yang J-R, He Y-N et al (2012b) Accelerated senescence of renal tubular epithelial cells is associated with disease progression of patients with immunoglobulin a (IgA) nephropathy. Transl Res 159:454–463. https://doi.org/10.1016/j.trsl.2011.11.008
67. Löbrich M, Jeggo PA (2007) The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Nat Rev Cancer 7:861–869. https://doi.org/10.1038/nrc2248
68. Lu D, Rauhauser A, Li B et al (2016) Loss of Glis2/NPHP7 causes kidney epithelial cell senescence and suppresses cyst growth in the Kif3a mouse model of cystic kidney disease. Kidney Int 89:1307–1323. https://doi.org/10.1016/j.kint.2016.03.006
69. Malaquin N, Carrier-Leclerc A, Dessureault M, Rodier F (2015) DDR-mediated crosstalk between DNA-damaged cells and their microenvironment. Front Genet 6:94. https://doi.org/10.3389/fgene.2015.00094
70. Mao S, Xu H, Zou L et al (2014) Estrogen preserves split renal function in a chronic complete unilateral ureteral obstruction animal model. Exp Ther Med 7:1555–1562. https://doi.org/10.3892/etm.2014.1663
71. Mason KD, Carpinelli MR, Fletcher JI et al (2007) Programmed anuclear cell death delimits platelet life span. Cell 128:1173–1186. https://doi.org/10.1016/j.cell.2007.01.037
72. Matjusaitis M, Chin G, Sarnoski EA, Stolzing A (2016a) Biomarkers to identify and isolate senescent cells. Ageing Res Rev 29:1–12. https://doi.org/10.1016/j.arr.2016.05.003
73. Matjusaitis M, Chin G, Sarnoski EA, Stolzing A (2016b) Biomarkers to identify and isolate senescent cells. Ageing Res Rev 29:1–12. https://doi.org/10.1016/j.arr.2016.05.003
74. Megyesi J, Andrade L, Vieira JM et al (2001) Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure. Kidney Int 60:2164–2172. https://doi.org/10.1046/j.1523-1755.2001.00044.x
75. Melk A, Kittikowit W, Sandhu I et al (2003) Cell senescence in rat kidneys in vivo increases with growth and age despite lack of telomere shortening. Kidney Int 63:2134–2143. https://doi.org/10.1046/j.1523-1755.2003.00032.x
76. Melk A, Schmidt BMW, Takeuchi O et al (2004) Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int 65:510–520. https://doi.org/10.1111/j.1523-1755.2004.00438.x
77. Melk A, Schmidt BMW, Vongwiwatana A et al (2005) Increased expression of senescence-associated cell cycle inhibitor p16INK4a in deteriorating renal transplants and diseased native kidney. Am J Transplant 5:1375–1382. https://doi.org/10.1111/j.1600-6143.2005.00846.x
78. Melk A, Schmidt BMW, Braun H et al (2009) Effects of donor age and cell senescence on kidney allograft survival. Am J Transplant 9:114–123. https://doi.org/10.1111/j.1600-6143.2008.02500.x
79. Molitoris BA, Dagher PC, Sandoval RM et al (2009) siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. J Am Soc Nephrol 20:1754–1764. https://doi.org/10.1681/ASN.2008111204
80. Ning Y-C, Cai G-Y, Zhuo L et al (2013) Short-term calorie restriction protects against renal senescence of aged rats by increasing autophagic activity and reducing oxidative damage. Mech Ageing Dev 134:570–579. https://doi.org/10.1016/j.mad.2013.11.006
81. Noren Hooten N, Martin-Montalvo A, Dluzen DF et al (2016) Metformin-mediated increase in DICER1 regulates microRNA expression and cellular senescence. Aging Cell 15:572–581. https://doi.org/10.1111/acel.12469
82. O'Hare T, Walters DK, Stoffregen EP et al (2005) In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants. Cancer Res 65:4500–4505. https://doi.org/10.1158/0008-5472.CAN-05-0259
83. O'Sullivan ED, Hughes J, Ferenbach DA (2017) Renal aging: causes and consequences. J Am Soc Nephrol 28:407–420. https://doi.org/10.1681/ASN.2015121308
84. Park J-Y, Schutzer WE, Lindsley JN et al (2007) p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levels. BMC Nephrol 8:12. https://doi.org/10.1186/1471-2369-8-12
85. Prakash J, de Borst MH, Lacombe M et al (2008) Inhibition of renal rho kinase attenuates ischemia/reperfusion-induced injury. J Am Soc Nephrol 19:2086–2097. https://doi.org/10.1681/ASN.2007070794
86. Quimby JM, Maranon DG, Battaglia CLR et al (2013) Feline chronic kidney disease is associated with shortened telomeres and increased cellular senescence. Am J Physiol Renal Physiol 305:F295–F303. https://doi.org/10.1152/ajprenal.00527.2012
87. Ritschka B, Storer M, Mas A et al (2017) The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration. Genes Dev 31:172–183. https://doi.org/10.1101/gad.290635.116
88. Rodier F, Muñoz DP, Teachenor R et al (2011) DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J Cell Sci 124:68–81. https://doi.org/10.1242/jcs.071340
89. Russo M, Spagnuolo C, Tedesco I et al (2012) The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem Pharmacol 83:6–15. https://doi.org/10.1016/j.bcp.2011.08.010
90. Samuels-Lev Y, O'Connor DJ, Bergamaschi D et al (2001) ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 8:781–794. https://doi.org/10.1038/35101044
91. Scindia Y, Deshmukh U, Thimmalapura P-R, Bagavant H (2008) Anti-alpha8 integrin immunoliposomes in glomeruli of lupus-susceptible mice: a novel system for delivery of therapeutic agents to the renal glomerulus in systemic lupus erythematosus. Arthritis Rheum 58:3884–3891. https://doi.org/10.1002/art.24026
92. Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704–707. https://doi.org/10.1038/366704a0
93. Sharpless NE, Sherr CJ (2015) Forging a signature of in vivo senescence. Nat Rev Cancer 15:397–408. https://doi.org/10.1038/nrc3960
94. Shillingford JM, Leamon CP, Vlahov IR, Weimbs T (2012) Folate-conjugated rapamycin slows progression of polycystic kidney disease. J Am Soc Nephrol 23:1674–1681. https://doi.org/10.1681/ASN.2012040367
95. Sis B, Tasanarong A, Khoshjou F et al (2007) Accelerated expression of senescence associated cell cycle inhibitor p16INK4A in kidneys with glomerular disease. Kidney Int 71:218–226. https://doi.org/10.1038/sj.ki.5002039
96. Smith JR, Pereira-Smith OM (1996) Replicative senescence: implications for in vivo aging and tumor suppression. Science 273:63–67
97. Stein GH, Dulić V (1995) Origins of G1 arrest in senescent human fibroblasts. BioEssays 17:537–543. https://doi.org/10.1002/bies.950170610
98. Sturmlechner I, Durik M, Sieben CJ et al (2017) Cellular senescence in renal ageing and disease. Nat Rev Nephrol 13:77–89. https://doi.org/10.1038/nrneph.2016.183
99. Suana AJ, Tuffin G, Frey BM et al (2011) Single application of low-dose mycophenolate mofetil-OX7-immunoliposomes ameliorates experimental mesangial proliferative glomerulonephritis. J Pharmacol Exp Ther 337:411–422. https://doi.org/10.1124/jpet.110.176222
100. Sweetwyne MT, Pippin JW, Eng DG et al (2017) The mitochondrial-targeted peptide, SS-31, improves glomerular architecture in mice of advanced age. Kidney Int 91:1126–1145. https://doi.org/10.1016/j.kint.2016.10.036
101. Toussaint O, Dumont P, Dierick JF et al (2000) Stress-induced premature senescence. Essence of life, evolution, stress, and aging. Ann N Y Acad Sci 908:85–98
102. Tuffin G, Waelti E, Huwyler J et al (2005) Immunoliposome targeting to mesangial cells: a promising strategy for specific drug delivery to the kidney. J Am Soc Nephrol 16:3295–3305. https://doi.org/10.1681/ASN.2005050485
103. Verzola D, Gandolfo MT, Gaetani G et al (2008) Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy. Am J Physiol Renal Physiol 295:F1563–F1573. https://doi.org/10.1152/ajprenal.90302.2008
104. Wahab N, Cox D, Witherden A, Mason RM (2007) Connective tissue growth factor (CTGF) promotes activated mesangial cell survival via up-regulation of mitogen-activated protein kinase phosphatase-1 (MKP-1). Biochem J 406:131–138. https://doi.org/10.1042/BJ20061817
105. Wang Y, Chang J, Liu X et al (2016) Discovery of piperlongumine as a potential novel lead for the development of senolytic agents. Aging (Albany NY) 8:2915–2926. 10.18632/aging.101100
106. Westhoff JH, Hilgers KF, Steinbach MP et al (2008) Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a. Hypertension 52:123–129. https://doi.org/10.1161/HYPERTENSIONAHA.107.099432
107. Wilson WH, O'Connor OA, Czuczman MS et al (2010) Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity. Lancet Oncol 11:1149–1159. https://doi.org/10.1016/S1470-2045(10)70261-8
108. Wischnjow A, Sarko D, Janzer M et al (2016) Renal targeting: peptide-based drug delivery to proximal tubule cells. Bioconjug Chem 27:1050–1057. https://doi.org/10.1021/acs.bioconjchem.6b00057
109. Wolstein JM, Lee DH, Michaud J et al (2010) INK4a knockout mice exhibit increased fibrosis under normal conditions and in response to unilateral ureteral obstruction. Am J Physiol Renal Physiol 299:F1486–F1495. https://doi.org/10.1152/ajprenal.00378.2010
110. Xu X-M, Ning Y-C, Wang W-J et al (2015) Anti-Inflamm-aging effects of long-term caloric restriction via overexpression of SIGIRR to inhibit NF-κB signaling pathway. Cell Physiol Biochem 37:1257–1270. https://doi.org/10.1159/000430248
111. Xue W, Zender L, Miething C et al (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445:656–660. https://doi.org/10.1038/nature05529
112. Yang L, Besschetnova TY, Brooks CR, et al (2010) Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 16:535–43– 1p following 143. doi:https://doi.org/10.1038/nm.2144
113. Yosef R, Pilpel N, Tokarsky-Amiel R et al (2016) Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat Commun 7:11190. https://doi.org/10.1038/ncomms11190
114. Zhang H, Xiong Y, Beach D (1993) Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol Biol Cell 4:897–906
115. Zhang H, Nimmer PM, Tahir SK et al (2007) Bcl-2 family proteins are essential for platelet survival. Cell Death Differ 14:943–951. https://doi.org/10.1038/sj.cdd.4402081
116. Zhou H, Kato A, Yasuda H et al (2004) The induction of cell cycle regulatory and DNA repair proteins in cisplatin-induced acute renal failure. Toxicol Appl Pharmacol 200:111–120. https://doi.org/10.1016/j.taap.2004.04.003
117. Zhu Y, Tchkonia T, Pirtskhalava T et al (2015) The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 14:644–658. https://doi.org/10.1111/acel.12344
118. Zhu Y, Tchkonia T, Fuhrmann-Stroissnigg H et al (2016) Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Aging Cell 15:428–435. https://doi.org/10.1111/acel.12445
119. Zhu Y, Doornebal EJ, Pirtskhalava T et al (2017) New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463. Aging (Albany NY) 9:955–963. 10.18632/aging.101202